Cargando…
Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma
Axl is an oncogenic receptor tyrosine kinase that plays a role in many cancers. LIGHT (Lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells) is a ligand that induces robust anti-tumor immunity by enhancing the recruitment and activati...
Autores principales: | Lee, Eun-Hee, Kim, Eun-Mi, Young, Kon-Ji, Park, A-Reum, Choi, Ha-Rim, Lee, Hwa-Youn, Kim, Su-Man, Chung, Byung Yeoup, Park, Chul-Hong, Choi, Hyo Jin, Ko, Young-Hyeh, Bai, Hyoung-Woo, Kang, Hyung-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400533/ https://www.ncbi.nlm.nih.gov/pubmed/28423548 http://dx.doi.org/10.18632/oncotarget.15830 |
Ejemplares similares
-
Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer
por: Lee, Eun-Hee, et al.
Publicado: (2017) -
TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/β-catenin and Erk Signaling
por: Kim, Su-Man, et al.
Publicado: (2019) -
Dexamethasone modified by gamma-irradiation as a novel anticancer drug in human non-small cell lung cancer
por: Lee, Eun-Hee, et al.
Publicado: (2018) -
Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota
por: Yee, Su-Min, et al.
Publicado: (2023) -
TREM2 promotes natural killer cell development in CD3(−)CD122(+)NK1.1(+) pNK cells
por: Lee, Hwa-Youn, et al.
Publicado: (2021)